CLINICAL TRIALS PROFILE FOR FYCOMPA
✉ Email this page to a colleague
All Clinical Trials for FYCOMPA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00903786 ↗ | A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) | Completed | Eisai Co., Ltd. | Phase 2 | 2009-06-17 | The purpose of this trial is to investigate the safety and tolerability of perampanel in long- term treatment in the patients with refractory partial epilepsy (uncontrolled with other anti-epileptic drugs) who completed Week 10 of Phase II Study E2007-J081-231 study. |
NCT02033902 ↗ | A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years | Completed | Eisai Inc. | 2014-06-06 | The purpose of this study is to evaluate the safety and tolerability of Fycompa (Perampanel) as an add-on therapy in epilepsy patients aged greater than or equal to 12 years. | |
NCT02220972 ↗ | To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures | Withdrawn | Eisai Inc. | Phase 4 | 2015-03-01 | This will be a multi-center, randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of 2007/Fycompa (perampanel) on sleep, in subjects with well controlled partial onset seizures (on an antiepileptic drug [AED] monotherapy) who are experiencing sleep onset insomnia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FYCOMPA
Condition Name
Clinical Trial Locations for FYCOMPA
Trials by Country
Clinical Trial Progress for FYCOMPA
Clinical Trial Phase
Clinical Trial Sponsors for FYCOMPA
Sponsor Name